Taiwan approves PharmaMar's treatment for small cell lung cancer as first-line maintenance therapy

Singapore, March 24 -- PharmaMar, a Spanish biopharmaceutical company with 40 years of experience, has announced that its treatment Zepzelca(R) (lurbinectedin), in combination with atezolizumab (Tecen... Read More

CHA Biotech and Novartis Korea partner to establish platform for biotech innovation

Singapore, March 24 -- CHA Biotech and Novartis Korea have signed a strategic Memorandum of Understanding (MoU) to establish a collaborative framework for bio open innovation based on the Cell Gene Bi... Read More

Japan's DNP establishes second overseas R&D base in IIT Hyderabad, India

Singapore, March 23 -- Japan's Dai Nippon Printing (DNP) will establish a new research and development base in Telangana, India, in April 2026, to advance and reinforce its global R&D strategy. The ba... Read More

Singapore accelerates multi-omics innovation in pharmaceutical sciences

Singapore, March 21 -- MGI Tech Singapore, and the Department of Pharmacy and Pharmaceutical Sciences in the National University of Singapore's Faculty of Science (NUS PPS) have announced a collaborat... Read More

Sandoz announces biosimilars partnership agreement with Korea's Samsung Bioepis

Singapore, March 21 -- Sandoz, the global leader in affordable medicines, has announced a major license, development and commercialisation partnership agreement with South Korea-based Samsung Bioepis,... Read More

Excalipoint Therapeutics Launches with $68.7M to Develop Next-Gen T-Cell Engager Therapies in China

Singapore, March 19 -- China-based startup Excalipoint Therapeutics, a biotechnology company developing next-generation T-cell engager (TCE) therapies for cancer and autoimmune diseases, has announced... Read More

Korea lays focus on expanding AI in public healthcare

Singapore, March 19 -- South Korea's Minister of Health and Welfare Jeong Eun Kyeong recently visited Seoul National University Bundang Hospital, and held a policy meeting on expanding artificial inte... Read More

Oxford Nanopore and A.D.A.M. Innovations to accelerate advanced genomic medicine in Japan

Singapore, March 19 -- UK-based Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate n... Read More

Excalipoint Therapeutics launches with $68.7 M to develop next-gen T-cell engager therapies in China

Singapore, March 19 -- China-based startup Excalipoint Therapeutics, a biotechnology company developing next-generation T-cell engager (TCE) therapies for cancer and autoimmune diseases, has announced... Read More

Eli Lilly invests additional 20 B yen in Japan to enhance pharma supply capacity

Singapore, March 17 -- Eli Lilly Japan K.K. has decided to invest 20 billion yen in its Seishin Plant (Kobe City, Hyogo Prefecture), the only manufacturing base for its own products in Japan. In order... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»